Follow Clinical Cancer Research for innovative clinical trials and precision medicine. Published by @AACR.
Joined July 2018
- Tweets 7,182
- Following 249
- Followers 8,291
- Likes 970
3,427 Photos and videos
Now online: The biology of hypomorphic TP53 variants and implications for clinical management doi.org/10.1158/1078-0432.CC…
2
1
151
Now online: First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma doi.org/10.1158/1078-0432.CC…
1
2
6
220
Now online: Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205 doi.org/10.1158/1078-0432.CC…
2
1
118
Now online: Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma doi.org/10.1158/1078-0432.CC…
1
4
193
Now online: Enfortumab Vedotin plus Pembrolizumab as First-line Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results from EV-202 Cohort 9 doi.org/10.1158/1078-0432.CC…
3
3
274
Now online: Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy doi.org/10.1158/1078-0432.CC…
3
4
137
Now online: Second Primary Malignancy Risk in Patients with Multiple Myeloma Receiving CAR T-Cell Therapy or Other Systemic Anticancer Treatments: A Real-World Comparative Study doi.org/10.1158/1078-0432.CC…
2
3
109
Now online: PiggyBac-Engineered Membrane-Bound IL7 TILs Combined with Anti–PD-1 Antibody Demonstrates Efficacy in Recurrent Ovarian Cancer: A First-in-Human Phase I Trial doi.org/10.1158/1078-0432.CC…
3
5
292
Now online: Phenotypic and Functional Characteristics of CD8 T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma doi.org/10.1158/1078-0432.CC…
1
5
170
Now online: Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial doi.org/10.1158/1078-0432.CC…
1
3
6
182
Now online: TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial doi.org/10.1158/1078-0432.CC…
1
4
3
256
Now online: Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial doi.org/10.1158/1078-0432.CC…
4
4
226
Now online: Single-Cell Transcriptomics Reveals Immune Landscape Dynamics in Metastatic Hormone Receptor–Positive Breast Cancer Treated with Abemaciclib and Endocrine Therapy doi.org/10.1158/1078-0432.CC…
3
3
198
Now online: A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastoma doi.org/10.1158/1078-0432.CC…
2
3
224
Now online: Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses doi.org/10.1158/1078-0432.CC…
3
2
196
Now online: Evaluation of Tissue from Patients with Prostate Cancer Identifies B7-H3 as an Androgen-Regulated, Broadly Expressed, Combinatorial Therapeutic Target doi.org/10.1158/1078-0432.CC…
1
110
Now online: The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma doi.org/10.1158/1078-0432.CC…
2
1
205
Now online: Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer doi.org/10.1158/1078-0432.CC…
1
135
Now online: The SOS1 Inhibitor BI 1701963 as Monotherapy or in Combination with Trametinib in Patients with KRAS Mutation-Positive Solid Tumors doi.org/10.1158/1078-0432.CC…
1
159